- Terrific acceleration at BioLife and it’s no surprise that the share price has gone parabolic.
- Revenue growth is accelerating, gross margins are increasing, there is a great deal of operational leverage and the company generates cash.
- Unfortunately, valuation is already such that we can’t advice buying at this time.
BioLife Is Going Parabolic
July 20th, 2018 · No Comments